{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:48:18Z","timestamp":1789386498887,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.neuropharm.2008.06.041","type":"journal-article","created":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T08:42:01Z","timestamp":1214642521000},"page":"737-742","source":"Crossref","is-referenced-by-count":13,"title":["Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures"],"prefix":"10.1016","volume":"55","author":[{"given":"Francesca","family":"Vaglini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Viaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Caramelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni U.","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.06.041_bib1","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1096\/fj.05-5510fje","article-title":"Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons","volume":"20","author":"Aiqun","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1749-6632.2002.tb04167.x","article-title":"Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity","volume":"965","author":"Battaglia","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib3","first-page":"541","article-title":"The effect of apomorphine and that of adrenalin, on the tremor of Parkinson's disease","volume":"114","author":"Barcroft","year":"1951","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib4","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.bcp.2004.02.015","article-title":"Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders","volume":"67","author":"Ben-Shachar","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(01)01491-1","article-title":"Apomorphine, dopamine, and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate 1","volume":"433","author":"Chiarenza","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib6","article-title":"Apomorphine and other dopaminomimetics","volume":"vols. 1 and 2","author":"Corsini","year":"1981"},{"key":"10.1016\/j.neuropharm.2008.06.041_bib7","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-3-662-06765-9_11","article-title":"Molecular and cellular events regulating dopamine neuron survival","volume":"vol. 154","author":"Corsini","year":"2002"},{"key":"10.1016\/j.neuropharm.2008.06.041_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2008.06.041_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-2952(00)00524-4","article-title":"Toxic effects of apomorphine on rat cultured neurons and glial C6 cells, and protection with antioxidants","volume":"66","author":"El Bach\u00e0","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/BF00403900","article-title":"Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats","volume":"10","author":"Ernst","year":"1967","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.neuropharm.2008.06.041_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(96)00291-9","article-title":"Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction","volume":"308","author":"Gassen","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/mds.870130409","article-title":"Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine","volume":"13","author":"Gassen","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1471-4159.2001.t01-1-00227.x","article-title":"Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss","volume":"77","author":"Grunblatt","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib14","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1046\/j.1460-9568.2002.02256.x","article-title":"Apomorphine induces trophic factors that support fetal rat mesencephalic dopaminergic neurons in cultures","volume":"16","author":"Guo","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib15","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1097\/00001756-199808030-00026","article-title":"Intrastriatal injection of dopamine results in DNA damage and apoptosis in rats","volume":"9","author":"Hattori","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2008.06.041_bib16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/jps.2600500323","article-title":"Auto-oxidation of apomorphine","volume":"50","author":"Kaul","year":"1961","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1248\/bpb1978.13.426","article-title":"Suppression of tumor cell growth and mitogen response by aporphine alkaloids, dicentrine, glaucine, corydine and apomorphine","volume":"13","author":"Kondo","year":"1990","journal-title":"J. Pharmacobiodyn."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib19","first-page":"1","article-title":"Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells","volume":"1","author":"Maggio","year":"2000","journal-title":"Neurotoxicity Res."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1471-4159.1981.tb01631.x","article-title":"Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates","volume":"36","author":"Maker","year":"1981","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib21","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1046\/j.1471-4159.1998.70062406.x","article-title":"Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by mitochondrial inhibitor","volume":"70","author":"McLaughlin","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0028-3908(03)00152-7","article-title":"Dose-dependent induction of apoptosis by R-apomorphine in CHO-K1 cell line in culture","volume":"45","author":"Pardini","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2008.06.041_bib23","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1073\/pnas.76.10.5387","article-title":"In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells","volume":"76","author":"Prochiantz","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib24","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1210\/jcem-71-6-1669","article-title":"Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents: presence of high affinity dopamine-D1 receptors","volume":"71","author":"Schrell","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C","article-title":"Cytotoxic and genotoxic potential of dopamine","volume":"55","author":"Stokes","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)02329-X","article-title":"Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by fx5-BSO and apoptosis","volume":"858","author":"Stokes","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tins.2007.03.009","article-title":"Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease","volume":"30","author":"Sulzer","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0891-5849(93)90055-Y","article-title":"Iron-reducing and free-radical-scavenging properties of apomorphine and some related benzylisoquinolines","volume":"15","author":"Ubeda","year":"1993","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0006-8993(96)00898-0","article-title":"l-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion","volume":"741","author":"Vaglini","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-2006-957749","article-title":"Inhibition of eukaryote protein kinases by isoquinoline and oxazine alkaloids","volume":"63","author":"Wang","year":"1997","journal-title":"Planta Med."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.1999.tb07977.x","article-title":"The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson's disease with iron chelators","volume":"890","author":"Youdim","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1006\/bbrc.1998.9044","article-title":"Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures","volume":"248","author":"Zhang","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2008.06.041_bib34","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0024-3205(99)00062-4","article-title":"Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity","volume":"64","author":"Zou","year":"1999","journal-title":"Life Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808002013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808002013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,12]],"date-time":"2021-09-12T18:55:41Z","timestamp":1631472941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808002013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0028390808002013"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.06.041","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}